AzTrials
AzTrials

Common Bile Duct StonesNCT02144493

Risk Factors for Recurrence of Primary Bile Duct Stones

An observational study of Common Bile Duct Stones, run by Chuncheon Sacred Heart Hospital at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Recurrent common bile duct stone is one of the risk factors of recurrent cholangitis. However, the exact pathophysiology or mechanism of recurrent cholangitis has not been established. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Common Bile Duct Stones
What is being tested?
The existence of periampullary diverticulum and CBD angle
How many people
2 participants
Where
1 siteSouth Korea
Study dates
May 2014to Dec 2014
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients who were diagnosed as CBD stone or calculous cholangitis will be enrolled. These patients will be divided by patienst with recurrent CBD stone (devlopment of CBD stone after 1 year from the first development of CBD stone) or not .

Who may be able to join

  • Patients who were performed ERCP due to CBD stone or calculous cholangitis

Who cannot join

  • Patients with biliary stricture, PSC, retained GB stone, or who were lost to follow-up.

Trial locations and contacts

1 site in 1 country.

Jai Hoon Yoon, M.D.,Ph.D. contact

+821032553957

jaihoonyoon@gmail.com

South Korea1 site, 1 recruiting
  • Chuncheon Sacred Heart Hospital

    Chuncheon, Gangwon-do, 200704

    Young Hee Lee, 82332405128, hcslib128@hallym.or.kr

    Chang Seok Bang, M.D.

    Recruiting

Other trials in South Korea

About this study

Official title: Case-control Study of Risk Factors for Recurrence of Primary Bile Duct Stones

Recurrent common bile duct stone is one of the risk factors of recurrent cholangitis. However, the exact pathophysiology or mechanism of recurrent cholangitis has not been established. Periampullary diverticulum and narrow angle of common bile duct have been postulated as risk factors of recurrent common bile duct stone. The aim of this study was to evaluate the association between periampullary dierticulum, angle of common bile duct and recurrent common bile duct stone.

Read the detailed description

Recurrent common bile duct stone is one of the risk factors of recurrent cholangitis. However, the exact pathophysiology or mechanism of recurrent cholangitis has not been established. Periampullary diverticulum and narrow angle of common bile duct have been postulated as risk factors of recurrent common bile duct stone. The aim of this study was to evaluate the association between periampullary dierticulum, angle of common bile duct and recurrent common bile duct stone.

This study is patient-control setting study. Firstly, from July 2007 through February 2014, all the patients who were performed ERCP will be enrolled. The inclusion criteria is the patients with common bile duct stone. The exclusion criteria is patients with biliary stenosis, PSC, retained GB stone, or who were lost to follow-up. The main outcome is the association between periampullary diverticulum, common bile duct angle, and recurrent CBD stone. This will be evaluated by univariate and multivariate analyses.

Being tested
The existence of periampullary diverticulum, CBD angle
Keywords
common bile duct stones, diverticulum
Medical subject headings
Diverticulum

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The existence of periampullary diverticulumOther

    Periampullary diverticulum has been postulated as risk factor of recurrent CBD stone.

  • CBD angleOther

    Narrow CBD angle has been postulated as risk factor for the development of recurrent CBD stone

Study groups in NCT02144493
Study groupRoleWhat they receive
Patients with recurrent CBD stoneNot described
Receives: Other: The existence of periampullary diverticulum; Other: CBD angle
Patients without recurrent CBD stoneNot described
Receives: Other: The existence of periampullary diverticulum; Other: CBD angle

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The association between existence of periampullary diverticulum and recurrent CBD stone

    The association between existence of periampullary diverticulum and recurrent CBD stone will be assessed by univariate analysis.(unit of analysis: odds ratio, statistical method: Fisher's exact test)

    Measured: retrospective (up to 8 years)

Secondary outcomes (1)
  1. The association between common bile duct angle and existence of recurrent CBD stone

    The association between common bile duct angle and recurrent CBD stone will be assessed by univariate analysis (unit of analysis: angle, statistical method: student's t test)

    Measured: retrospective (up to 8 years)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 May 2014 (estimated)
  2. Study startMay 2014
  3. Primary completionDec 2014 (estimated)
  4. Study completionDec 2014 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
2 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02144493
Sponsor's protocol ID
YJH-1
Other IDs
ChuncheonSHH YJH-1
Status last verified
May 2014
First submitted
12 May 2014
Last updated
22 May 2014
Results posted
No
Data monitoring committee
No

Publications

  • Keizman D, Shalom MI, Konikoff FM. An angulated common bile duct predisposes to recurrent symptomatic bile duct stones after endoscopic stone extraction. Surg Endosc. 2006 Oct;20(10):1594-9. doi: 10.1007/s00464-005-0656-x. Epub 2006 Jul 20.

    PubMed 16858527
  • Katsinelos P, Chatzimavroudis G, Tziomalos K, Zavos C, Beltsis A, Lazaraki G, Terzoudis S, Kountouras J. Impact of periampullary diverticula on the outcome and fluoroscopy time in endoscopic retrograde cholangiopancreatography. Hepatobiliary Pancreat Dis Int. 2013 Aug;12(4):408-14. doi: 10.1016/s1499-3872(13)60063-6.

    PubMed 23924499
  • Panteris V, Vezakis A, Filippou G, Filippou D, Karamanolis D, Rizos S. Influence of juxtapapillary diverticula on the success or difficulty of cannulation and complication rate. Gastrointest Endosc. 2008 Nov;68(5):903-10. doi: 10.1016/j.gie.2008.03.1092. Epub 2008 Jul 16.

    PubMed 18635174

Questions about this trial

What is this clinical trial studying?

An observational study of Common Bile Duct Stones, run by Chuncheon Sacred Heart Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 May 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jai Hoon Yoon, M.D.,Ph.D. (+821032553957, jaihoonyoon@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The association between existence of periampullary diverticulum and recurrent CBD stone (time frame: retrospective (up to 8 years)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02144493, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 May 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in